close

Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples primarily in the United States. The company provides commercial testing and confirmation by mass spectrometry to detect the presence of drugs of abuse, such as cocaine, marijuana, and PCP; methamphetamine, including ecstasy; and opiates that include heroin, hydrocodone, hydromorphone, and oxycodone. Its tests provide information that indicates the approximate amount of drug ingested, as well as historical data, which shows a pattern of individual drug used over a period of time. The company serves employers for applicant and employee testing, as well as physicians, treatment professionals, law enforcement agencies, school administrators, parents concerned about their children's drug use, and other individuals or entities engaged in business where drug use or potential drug use is an issue. Psychemedics primarily markets its corporate drug testing services through its own sales force; and home drug testing services through the Internet and retail distributors. The company was founded in 1985 and is based in Acton, Massachusetts.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	9.90
Volume	8857
Volume Avg	16126
52 Week High	11.12
52 Week Low	6.85
PE	14.78
PE (group average)	39
EPS Year	0.67
EPS change Q/Q	100%
EPS change Q/Q Yr ago	60%
EPS change Q/Q next Q est	-100%
EPS change Y/Y	-31.58%
REV change Q/Q	17.65%
REV change Q/Q Yr ago	33.33%
EPS next Q est	0.00
EPS next Y est	0.00
Divident Annual	0.51
Dividend Yield	5.15%